| | 148016-81-3 Basic information More.. |
| Product Name: | Doripenem | | Synonyms: | (+)-(4r,5s,6s)-6-[(1r)-1-hydro-xyethyl]-4-methyl-7-oxo-3-[[(3s,5s)-5-[(sulfamoylamino)-methyl]-3-pyrrolidinyl]thio]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;DORIPENEM;Doripenem／(+)-(4R,5S,6S)-6-[(1R)-1-Hydro-xyethyl]-4-methyl-7-oxo-3-[[(3S,5S)-5-[(sulfamoylamino)-methyl]-3-pyrrolidinyl]thio]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;(4R,5S,6S)-3-[[(3S,5S)-5-[[(Aminosulfonyl)amino]methyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid;S 4661;(4R,5S,6S)-6-((R)-1-hydroxyethyl)-4-Methyl-7-oxo-3-((3S,5S)-5-((sulfaMoylaMino)Methyl)pyrrolidin-3-ylthio)-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;InterMediates of DoripeneM;DoripeneM Monohydrate | | CAS: | 148016-81-3 | | MF: | C15H24N4O6S2 | | MW: | 420.5 | | EINECS: | 1308068-626-2 | | Mol File: | 148016-81-3.mol |  |
Use
Doripenem is a parenteral carbapenem antibiotic launched in Japan for the treatment of bacterial respiratory and urinary tract infections. It is a 1β-methyl carbapenem derivative, and it is the fourth analog to be marketed in this series following the launch of meropenem, biapenem, and ertapenem in previous years. The introduction of a 1β-methyl group to the carbapenem skeleton enhances metabolic stability to renal dehydropeptidase-1 (DHP-1) and leads to improved antibacterial potency.
- Doripenem
-
- US $0.00 / kg
- 2024-04-29
- CAS:148016-81-3
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 20tons
- Doripenem
-
- US $0.00 / kg
- 2024-04-12
- CAS:148016-81-3
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 2000ton
- Doripenem
-
- US $0.00-0.00 / mg
- 2024-04-10
- CAS:148016-81-3
- Min. Order: 10mg
- Purity: 90%+
- Supply Ability: 10g
|
|
148016-81-3
Recommend Suppliers |
|